DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20190650

Study of prescription patterns of antihypertensive agents in preeclampsia patients: Central India study

Shreya Shekhar, Tanaji R. Shende, A. S. Borkar, Riyaz Siddiqui, Sulabha A. Joshi

Abstract


Background: The main objective of this study was to evaluate prescription patterns of antihypertensives in preeclampsia patients at a tertiary care hospital in Central India.

Methods: The study belongs to retrospective observational type. he study was conducted by department of Pharmacology in association of department of Obstetrics & Gynaecology department at Nkp Salve Institute of Medical Sciences & Research Centre, Lata Mangeshkar Hospital, Nagpur. Permission from Institute Ethics Committee was taken for studying the prescribing patterns of drugs. The study was conducted for a period of 6 months. Inclusion and Exclusion criteria were added.

Results: The maximum number patients seen in age groups 36-41 (28.6%). The main drug prescribed in our study was Labetalol followed by methyldopa. In our study most of the patients were of moderate and mild type corresponding to 48% and 32% respectively and only 20% of patients belong to severe cases. In our study highest number of patients was seen in second gravida i.e. 33.33%.

Conclusions: Labetalol was the most common anti hypertensive prescribed in pre eclampsia patients. Rationale prescribing of drugs were done.


Keywords


Antihypertensives, Hypertension, Preeclampsia

Full Text:

PDF

References


Redman CW. Hypertension in pregnancy:the NICE guidelines. Heart. 2011;97:1967-9.

Roberts J, Pearson G, Cutler J, Lindheimer M. Summary of the NHLBI working group on research on hypertension during pregnancy. Hypertens. 2003;41(3):437-45.

Shrank WH, Hoang T, Ettner SL, et al. The implications of choice:prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions. Arch Intern Med. 2006;166(3):332–7.

Lambert G, Brichant JF, Hartstein G, Bonhomme V, Dewandre PY. Preeclampsia: an update. Acta Anaesthesiol Belg. 2014;65(4):137-49.

Yamakanamardi S, Anuradha HV, Sujani BK, Shivamurthy MC. Analysis of prescribing pattern of antihypertensive drugs during pregnancy and neonatal outcome in a tertiary care centre. Int J Basic Clin Pharmacol. 2016;5:718-21.

Folic M, Folic N, Varjacic M, Jakovljevic M, Jankovic S. Antihypertensive drug therapy for hypertensive disorders in pregnancy. Acta Medica Medianae. 2008;47(3):67-71

T Naveen Kumar, Tadvi NA, Kaul R. Prescription pattern of drugs in pregnancy induced hypertension in a tertiary care hospital. Int J Basic Clin Pharmacol 2013;2:783-7.

JNC 7 express. The seventh report of the Joint National committee on prevention, detection, evaluation and treatment of high blood pressure. Available at: http://www.nhlbi.nih.gov/guidelines/ hypertension/ex press.pdf. Accessed on 28 January 2016.

Kauntiz AM, Hughes JM, Grimes DH, Smith JC, Rochat RW, Kaffrissen ME. Causes of maternal mortality in the United States of America. J Obstetr Gynecol. 1985;65:605-12.

Sheraz S, Shahzad S, Boota M. Eclampsia. Prof Med J. 2006;13(1):27-31.

Zibaeenazhad MJ, M Ghodsi P Arab, Gholzom N. the prevalence of hypertensive disorders of pregnancy in Shiraz, Southern Iran; Iranian Cardiovascular Res J. 2010;4:169-72.

Sajith M, Nimbargi V, Modi A, Sumariya R, Pawar A. Incidence of pregnancy induced hypertension and prescription pattern of antihypertensive drugs in pregnancy. Int J Pharma Sci Res. 2014;23:4.

Ramkumar K, Anju AS, Kandel P, Vishwanath BA, Kumar P. A study on prescribing pattern of antihypertensive drugs during pregnancy in tertiary care hospital, banglore. Indo Am J Pharm Res. 2016;6;09:6537-46.

Gersak K, Cvijic M, Cerar LK. Angiotensin II receptor blockers in pregnancy:a report of five cases. Reprod Toxicol. 2009;28(1):109-12.

Girija SD. Labetalol-An emerging first line drug for pregnancy induced hypertension. Indian J Clin Prac. 2013;23:640-1.

Abalos E, Duley L, Steyn DW, Henderson-smart DJ. Antihypertensive drug therapy to mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2003;1:CD002252.